Dr. Markman Discusses the Olaparib Phase II Trial

Maurie Markman, MD
Published Online: Wednesday, May 18, 2011
Maurie Markman, MD the National Director for Medical Oncology for the Cancer Treatment Centers of America Discusses the Olaparib Phase II Trial
Maurie Markman, MD the National Director for Medical Oncology for the Cancer Treatment Centers of America Discusses the Olaparib Phase II Trial
Online CME Activities
TitleExpiration DateCME Credits
PARP Inhibitors: Current and Future Options for Breast and Ovarian CancerJun 20, 20161.0
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Gynecologic CancersJul 31, 20162.5